BiotechTube

Adventan® (methylprednisolone aceponate 0,1%)

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Allergic Contact Eczema

Conditions

Allergic Contact Eczema

Trial Timeline

Feb 1, 2012 → May 1, 2012

NCT ID
NCT01529320

About Adventan® (methylprednisolone aceponate 0,1%)

Adventan® (methylprednisolone aceponate 0,1%) is a phase 1 stage product being developed by Bayer for Allergic Contact Eczema. The current trial status is completed. This product is registered under clinical trial identifier NCT01529320. Target conditions include Allergic Contact Eczema.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01529320Phase 1Completed

Competing Products

20 competing products in Allergic Contact Eczema

See all competitors
ProductCompanyStageHype Score
BriquilimabJasper TherapeuticsPhase 1
25
LY3650150 + Placebo + Standard therapy for INCSEli LillyPhase 3
77
Lesigercept + PlaceboYuhanPhase 2
52
YH35324 + Omalizumab + PlaceboYuhanPhase 1
33
Bilastine + Desloratadine + PlaceboYuhanPhase 3
77
ASP2390 + PlaceboAstellas PharmaPhase 1
33
ASP4070 + PlaceboAstellas PharmaPhase 2
52
S-555739 Dose 1 + S-555739 Dose 2 + Cetirizine HCl Dose 1 + S-555739 placebo + Cetirizine HCl placeboShionogiPhase 2
52
Cetirizine + High dose ONO-4053 + Low dose ONO-4053 + PlaceboOno PharmaceuticalPhase 2
52
Prednisolone + VoriconazoleCiplaPhase 2/3
65
placebo, isotonic ciclesonide, hypotonic ciclesonideSumitomo PharmaApproved
85
ciclesonide nasal aerosol + ciclesonide nasal spraySumitomo PharmaApproved
85
ciclesonide hydrofluoroalkane (HFA) nasal aerosol + mometasone nasal inhalationSumitomo PharmaPhase 3
77
Ciclesonide nasal aerosol 37 mcg + ciclesonide nasal aerosol 74 mcg + PlaceboSumitomo PharmaPhase 3
77
ciclesonide nasal aerosol + mometasone Aqueous (AQ) nasal spraySumitomo PharmaPhase 1
33
ciclesonide + mometasoneSumitomo PharmaPhase 3
77
DSP-3025 + PlaceboSumitomo PharmaPhase 1
33
ciclesonide nasal aerosol + PlaceboSumitomo PharmaPhase 3
77
Ciclesonide HFA 80 mcg + Ciclesonide HFA 160 mcg + PlaceboSumitomo PharmaPhase 3
77
Ciclesonide HFA Nasal Aerosol 320 mcg + Ciclesonide HFA Nasal Aerosol 160 mcg + HFA Nasal Aerosol placebo + Ciclesonide Aqueous Nasal Spray 200 mcg + AQ Nasal Spray Placebo + Placebo plus Dexamethasone HFA + Placebo AQ plus Dexamethasone 6 mgSumitomo PharmaPhase 3
77

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82